|
US6172100B1
(en)
|
1997-04-30 |
2001-01-09 |
Eli Lilly And Company |
Antithrombotic agents
|
|
JP2001523256A
(ja)
|
1997-05-01 |
2001-11-20 |
イーライ・リリー・アンド・カンパニー |
抗血栓物質
|
|
ID24568A
(id)
*
|
1997-11-06 |
2000-07-27 |
American Home Prod |
Kontrasepsi oral yang mengandung anti-estrogen plus progestin
|
|
US6069153A
(en)
*
|
1998-05-12 |
2000-05-30 |
American Home Products Corporation |
Indenoindoles and benzocarbazoles as estrogenic agents
|
|
ATE339415T1
(de)
*
|
1998-05-12 |
2006-10-15 |
Wyeth Corp |
Benzocarbazol und indenoindole derivate als östrogene agentien
|
|
EP1080073A1
(en)
*
|
1998-05-15 |
2001-03-07 |
American Home Products Corporation |
Compositions comprising 2-phenyl-indole compounds and estrogen formulations
|
|
PT1076558E
(pt)
*
|
1998-05-15 |
2003-11-28 |
Wyeth Corp |
2-fenil-1-¬4-(2-aminoetoxi)-benzil|-indole em combinacao com estrogenios
|
|
US6479535B1
(en)
|
1998-05-15 |
2002-11-12 |
Wyeth |
2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole and estrogen formulations
|
|
US7005428B1
(en)
|
1998-06-11 |
2006-02-28 |
Endorecherche, Inc. |
Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
|
|
US6465445B1
(en)
|
1998-06-11 |
2002-10-15 |
Endorecherche, Inc. |
Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
|
|
DE69914563T2
(de)
|
1998-10-30 |
2004-12-16 |
Eli Lilly And Co., Indianapolis |
Azaindol derivate und ihre Verwendung als antithrombotische Wirkstoffe
|
|
TWI220898B
(en)
*
|
1999-03-04 |
2004-09-11 |
Wyeth Corp |
N-substituted indolines as estrogenic agents
|
|
AU3859400A
(en)
*
|
1999-03-04 |
2000-09-21 |
American Home Products Corporation |
N-substituted benzoyl indoles as estrogenic agents
|
|
US6358943B1
(en)
|
1999-03-04 |
2002-03-19 |
American Home Products Corporation |
N-substituted indolines as estrogenic agents
|
|
US6380185B1
(en)
|
1999-03-04 |
2002-04-30 |
American Home Products Corporation |
N-substituted benzoyl indoles as estrogenic agents
|
|
HUP0202679A3
(en)
*
|
1999-09-13 |
2003-04-28 |
Wyeth Corp |
Glucopyranosides conjugates of 2-(4-hydroxy-phenyl)-1-[4-(2-amin-1-yl-ethoxy)-benzyl]-1h-indol-5-ols, process for their preparation and pharmaceutical compositions containing them
|
|
US6380166B1
(en)
|
1999-09-13 |
2002-04-30 |
American Home Products Corporation |
Glucopyranosides conjugates of 2-(4-hydroxy-phenyl)-3-methyl-1-[4-(2-amin-1-yl-ethoxy)-benzyl]-1H-indol-5-ols
|
|
IL149990A0
(en)
*
|
2000-01-28 |
2002-12-01 |
Endorech Inc |
Selective estrogen receptor modulators in combination with estrogens
|
|
US20020013327A1
(en)
*
|
2000-04-18 |
2002-01-31 |
Lee Andrew G. |
Compositions and methods for treating female sexual dysfunction
|
|
AR029538A1
(es)
*
|
2000-07-06 |
2003-07-02 |
Wyeth Corp |
Composiciones farmaceuticas de agentes estrogenicos
|
|
US20020016318A1
(en)
*
|
2000-07-06 |
2002-02-07 |
American Home Products Corporation |
Methods of treating breast disorders
|
|
CN1452497A
(zh)
*
|
2000-07-06 |
2003-10-29 |
惠氏公司 |
Ssri和雌激素制剂的联合药物形式
|
|
BR0112360A
(pt)
*
|
2000-07-06 |
2003-05-06 |
Wyeth Corp |
Método para aumentar a atividade da sintase de óxido nìtrico
|
|
AR030064A1
(es)
*
|
2000-07-06 |
2003-08-13 |
Wyeth Corp |
Metodos para inhibir los efectos uterotroficos de los agentes estrogenicos
|
|
WO2002003988A2
(en)
*
|
2000-07-06 |
2002-01-17 |
Wyeth |
Use of substituted indole compounds for treating neuropeptide y-related conditions
|
|
AU2001271781A1
(en)
*
|
2000-07-06 |
2002-01-21 |
Wyeth |
Use of substituted indole compounds for treating sphincter incontinence
|
|
WO2002003990A2
(en)
*
|
2000-07-06 |
2002-01-17 |
Wyeth |
Use of substituted insole compounds for treating excessive intraocular pressure
|
|
AU2001271784A1
(en)
*
|
2000-07-06 |
2002-01-21 |
Wyeth |
Therapy for prosthesis-related bone degeneration
|
|
EP1656938A1
(en)
|
2000-07-06 |
2006-05-17 |
Wyeth |
Combinations of SSRI and estrogenic agents
|
|
EP1177787A3
(en)
*
|
2000-07-28 |
2003-09-10 |
Pfizer Products Inc. |
Use of an estrogen agonist/antagonist for treating cataracts
|
|
WO2002094788A1
(en)
|
2001-05-22 |
2002-11-28 |
Eli Lilly And Company |
2-substituted 1,2,3,4-tetrahydroquinolines and derivatives thereof, compositions and methods
|
|
US6962928B2
(en)
|
2001-05-22 |
2005-11-08 |
Eli Lilly And Company |
Tetrahydroquinoline derivatives for the inhibition of osteoporosis, estrogen dependent breast cancer, endometriosis and uterine fibrosis
|
|
UA85374C2
(en)
*
|
2002-06-13 |
2009-01-26 |
Уайт |
bazedoxifene treatment regimen
|
|
CN1668303B
(zh)
|
2002-07-22 |
2010-10-27 |
伊莱利利公司 |
含苯磺酰基的选择性雌激素受体调节剂
|
|
AU2003292625B2
(en)
|
2002-12-26 |
2008-07-24 |
Eisai R & D Management Co., Ltd. |
Selective estrogen receptor modulators
|
|
US7250440B2
(en)
*
|
2003-08-12 |
2007-07-31 |
Wyeth |
(Hydroxyphenyl)-1H-indole-3-carbaldehyde oxime derivatives as estrogenic agents
|
|
BRPI0509191A
(pt)
|
2004-04-07 |
2007-09-25 |
Wyeth Corp |
polimorfo cristalino, composição, métodos de preparar forma a polimórfica de acetato de bazedoxifeno, de tratar um mamìfero possuindo uma doença ou sìndrome associada com deficiência de estrogênio ou excesso de estrogênio, e com proliferação ou desenvolvimento anormal de tecidos endometriais, cáncer de mama em um mamìfero, e uma mulher pós-menopausal para um ou vários distúrbios vasomotores, de abaixar colesterol em um mamìfero, e de inibir perda óssea em um mamìfero, e, forma a polimorfa cristalina de acetato de bazedoxifeno
|
|
AU2005233114A1
(en)
|
2004-04-07 |
2005-10-27 |
Wyeth |
Crystalline polymorph of bazedoxifene acetate
|
|
BRPI0509385A
(pt)
|
2004-04-08 |
2007-09-18 |
Wyeth Corp |
composto, composição, métodos de preparar o sal, ea dispensão sólida, de tratar um mamìfero tendo uma doença ou sìndrome associadas com a deficiência de estrogênio ou excesso de estrogênio, uma doença ou distúrbio associados com a proliferação ou desenvolvimento anormal dos tecidos endometriais, de tratar cáncer de mama em um mamìfero, e uma mulher pós-menopáusica quanto a um ou mais distúrbios vasomotores, de reduzir colesterol, e de inibir perda óssea em um mamìfero, dispersão sólida, e, uso de um composto
|
|
US7868037B2
(en)
|
2004-07-14 |
2011-01-11 |
Ptc Therapeutics, Inc. |
Methods for treating hepatitis C
|
|
CA2573185A1
(en)
|
2004-07-14 |
2006-02-23 |
Ptc Therapeutics, Inc. |
Methods for treating hepatitis c
|
|
US7781478B2
(en)
|
2004-07-14 |
2010-08-24 |
Ptc Therapeutics, Inc. |
Methods for treating hepatitis C
|
|
US7772271B2
(en)
|
2004-07-14 |
2010-08-10 |
Ptc Therapeutics, Inc. |
Methods for treating hepatitis C
|
|
US7645881B2
(en)
|
2004-07-22 |
2010-01-12 |
Ptc Therapeutics, Inc. |
Methods for treating hepatitis C
|
|
US20060030591A1
(en)
*
|
2004-08-05 |
2006-02-09 |
Wyeth |
Crystalline polymorph of pipindoxifene hydrochloride monohydrate
|
|
SG155258A1
(en)
|
2004-10-20 |
2009-09-30 |
Endorech Inc |
Sex steroid precursors alone or in combination with a selective estrogen receptor modulator and/or with estrogens and/or a type 5 cgmp phosphodiesterase inhibitor for the prevention and treatment of vaginal dryness and sexual dysfunction in postmenopausa
|
|
FR2880625B1
(fr)
*
|
2005-01-07 |
2007-03-09 |
Sanofi Aventis Sa |
Derives de n-(heteroaryl)-1h-indole-2-carboxamides, leur preparation et leur application en therapeutique
|
|
US20100087661A1
(en)
*
|
2007-02-12 |
2010-04-08 |
Josef Jirman |
Method for the preparation of 5-benzyloxy-2-(4-benzyloxphenyl)-3-methyl-1h-indole
|
|
US8268806B2
(en)
|
2007-08-10 |
2012-09-18 |
Endorecherche, Inc. |
Pharmaceutical compositions
|
|
US8183367B2
(en)
*
|
2008-02-11 |
2012-05-22 |
Wyeth Llc |
Methods of preparing polymorphic form A of bazedoxifene acetate
|
|
BRPI0910656A2
(pt)
|
2008-04-16 |
2019-09-24 |
Karobio Ab |
´´compostos ligantes de receptor de estrogênio, uso dos mesmos e composição farmacéutica´´
|
|
CN102395561A
(zh)
*
|
2009-04-13 |
2012-03-28 |
桑多斯股份公司 |
合成巴多昔芬乙酸酯及其中间体的方法
|
|
US20100317635A1
(en)
|
2009-06-16 |
2010-12-16 |
Endorecherche, Inc. |
Treatment of hot flushes, vasomotor symptoms, and night sweats with sex steroid precursors in combination with selective estrogen receptor modulators
|
|
ITMI20091109A1
(it)
|
2009-06-23 |
2010-12-24 |
Wyeth Corp |
Forma polimorfa d di bazedoxifene acetato e metodi per la sua preparazione
|
|
KR20140089402A
(ko)
|
2010-06-16 |
2014-07-14 |
앙도르쉐르슈 인코포레이티드 |
에스트로겐-관련 질병의 치료 또는 예방 방법
|
|
US7968732B1
(en)
|
2010-09-07 |
2011-06-28 |
Divi's Laboratories, Ltd. |
Process for the preparation of 5-benzyloxy-2-(4-benzyloxyphenyl)-3-methyl-1H-indole
|
|
EP2616463A4
(en)
|
2010-09-14 |
2014-01-08 |
Reddys Lab Ltd Dr |
PREPARATION OF CRYSTALLINE BAZEDOXIFES AND THEIR SALTS
|
|
US8569483B2
(en)
|
2011-06-21 |
2013-10-29 |
Divi's Laboratories, Ltd. |
Process for the preparation of bazedoxifene acetate and intermediates thereof
|
|
CN102690225B
(zh)
*
|
2012-04-11 |
2014-12-24 |
南京友杰医药科技有限公司 |
巴多昔芬的合成方法
|
|
US9751835B2
(en)
*
|
2013-05-15 |
2017-09-05 |
Indiana University Research And Technology Corporation |
Processes and intermediates for preparing indole pharmaceuticals
|
|
US9744177B2
(en)
|
2014-03-10 |
2017-08-29 |
Endorecherche, Inc. |
Treatment of male androgen deficiency symptoms or diseases with sex steroid precursor combined with SERM
|
|
US9421264B2
(en)
|
2014-03-28 |
2016-08-23 |
Duke University |
Method of treating cancer using selective estrogen receptor modulators
|
|
DK3834824T3
(da)
|
2014-03-28 |
2025-12-01 |
Univ Duke |
Behandling af en østrogenreceptor-positiv brystkræft under anvendelse af en selektiv østrogenreceptormodulator
|
|
EP3233828B1
(en)
*
|
2014-12-18 |
2020-03-04 |
F. Hoffmann-La Roche AG |
Estrogen receptor modulators and uses thereof
|
|
KR20190110400A
(ko)
|
2018-03-20 |
2019-09-30 |
엠에프씨 주식회사 |
새로운 중간체를 이용한 바제독시펜의 제조방법
|
|
IT201800006562A1
(it)
*
|
2018-06-21 |
2019-12-21 |
|
Procedimento e intermedi utili per la preparazione di indoli
|
|
IT201900001923A1
(it)
|
2019-02-11 |
2020-08-11 |
Erregierre Spa |
Sali di bazedoxifene utili per la preparazione di bazedoxifene acetato
|
|
US11246874B1
(en)
|
2021-04-20 |
2022-02-15 |
Oxygen Biotech LLC |
Treatment of COVID-19
|